Key result
Cardiologist care links to ~53% greater ACEI/ARB adherence versus non-specialist care following heart failure discharge.
Why the study?
The effect of cardiologist care on adherence to evidence-based secondary prevention medications, mortality, and readmission in patients discharged with heart failure was unclear.
Does cardiologist care improve adherence to evidence-based medications and reduce mortality and readmission in patients discharged with heart failure?
Observational (n=2,650)
Does cardiologist care improve adherence to evidence-based medications and reduce mortality and readmission in patients discharged with heart failure?
Answers are grounded in this paper and cite their sources.
Cardiologist care for heart failure patients post-discharge improves adherence to guideline-directed medical therapy, which is associated with reduced mortality and readmissions.
OBJECTIVES: To evaluate the effect of cardiologist care on adherence to evidence-based secondary prevention medications, mortality and readmission within 6 months of discharge in patients with heart failure (HF). DESIGN: Retrospective observational study based on administrative data. SETTING: Local Healthcare Authority (LHA) of Bologna, one of the largest LHAs of Italy with ~870 000 inhabitants. PARTICIPANTS: All patients residing in the LHA of Bologna discharged from hospital with a diagnosis of HF between 1 January 2015 and 31 December 2015. PRIMARY AND SECONDARY OUTCOME MEASURES: Multivariable regression analysis was used to assess the association of inpatient and outpatient cardiologist care with adherence to evidence-based medications, all-cause mortality and hospital readmission (including emergency room visits) within 6 months of discharge. RESULTS: The study population included 2650 patients (mean age 82.3 years). 340 (12.8%) patients were discharged from cardiology wards, while 635 (24.0%) were seen by a cardiologist during follow-up. Inpatient and outpatient cardiologist care was associated with an increased likelihood of adherence to ACE inhibitors/angiotensin receptor blockers (ACEIs/ARBs), β-blockers and aldosterone antagonists after discharge. The risk of mortality was significantly lower among patients adherent to ACEIs/ARBs and/or β-blockers (-53% and -28%, respectively); the risk of hospital readmission was significantly lower among patients adherent to ACEIs/ARBs (-28%). CONCLUSIONS: Compared with non-specialist care, cardiologist care improves patient adherence to evidence-based medications and might thus favourably affect mortality and readmission following HF.
No takes yet. Share an insight, caveat, or question.
Avaldi et al. (2017) conducted an observational in Heart failure (n=2,650). Cardiologist care vs. Non-specialist care (Internal medicine) was evaluated on Adherence to ACE inhibitors/angiotensin receptor blockers (ACEIs/ARBs) after discharge (OR 1.53, 95% CI 1.03-2.28, p=<0.01). Cardiologist care improved patient adherence to evidence-based medications like ACE inhibitors/ARBs compared with non-specialist care following heart failure discharge.
Synapse has enriched 10 related papers. Consider them for comparative context: